Martindale Pharma, the UK-based leading international specialty pharmaceutical company, has announced that it is expanding its international footprint in Saudi Arabia by signing a new distribution agreement with its long-standing partner Faisal Musaed El Seif Saudi Pharmaceutical Co, one of the leading healthcare distributors in the country.
This agreement forms part of Martindale Pharma’s strategy to expand its international business and will actively support further growth of its Emergency Care and Hospital-initiated Medicines product range in the country.
In addition, Martindale Pharma has received marketing authorisations for six products in Saudi Arabia and has been awarded multiple products on the SGH 38 tender for supply to Ministry of Health Hospitals in Saudi Arabia and hospitals in UAE, Kuwait, Bahrain, Qatar and Oman.
Michael Harris, CEO of Martindale Pharma, said, ‘We are delighted to extend our strategic relationship with Faisal Musaed El Seif Saudi Pharmaceutical Co to make our portfolio of emergency care and hospital-initiated medicines available to healthcare providers in this growing market for pharmaceuticals. This extended and deepened
relationship coupled with national marketing authorisations for some of our emergency care products, will help drive sales in this key market.
‘Saudi Arabia is now our largest International market and we continue to see a strong opportunity for growth in this region, particularly in the area of analgesic and cardiovascular drugs. We are committed to working with Faisal Musaed El Seif Saudi Pharmaceutical Co and our other partners in this region to continue to make our products
more widely available.’
Under the new agreement with Faisal Musaed El Seif Saudi Pharmaceutical Co, Martindale Pharma’s portfolio will be promoted via a dedicated sales team to both private and public hospitals in Saudi Arabia.
